Opus Genetics (IRD) Other financing activities (2011 - 2026)
Opus Genetics (IRD) posted quarterly Other financing activities of $738000.0 for Q1 2026, up 14660.0% year-over-year from N/an in Q1 2025, and down 6.94% quarter-over-quarter from $793000.0 in Q4 2025.
Powered by 
Analysis
Opus Genetics (IRD) Other financing activities (2011 - 2026) Analysis & Trends
Opus Genetics (IRD) has reported Other financing activities for 11 consecutive years, with $738000.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Other financing activities rose 14660.0% year-over-year to $738000.0; the TTM figure through Mar 2026 stood at $1.6 million (up 30960.0% YoY), while the FY2025 annual figure was $820000.0, changed N/A from the prior year.
- Other financing activities fell to $738000.0 in Q1 2026 per IRD's latest filing, from $793000.0 in the prior quarter.
- Across five years, Other financing activities topped out at $793000.0 in Q4 2025 and bottomed at $5000.0 in Q1 2025.
- Historically, Other financing activities has averaged $269166.7 across 4 years, with a median of $28500.0 in 2022.
- Annual changes were most pronounced in 2022 — Other financing activities jumped 170.0% — and 2026, when it soared 14660.0%.
- Opus Genetics' Other financing activities stood at $27000.0 in 2022, then rose by 11.11% to $30000.0 in 2023, then surged by 2543.33% to $793000.0 in 2025, then retreated by 6.94% to $738000.0 in 2026.
- Business Quant data shows IRD's Other financing activities at $738000.0 in Q1 2026, $793000.0 in Q4 2025, and $22000.0 in Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn |
| 10 | Opus Genetics | 446.86 Mn | 358.05 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 925,000.00 |
| Mar 31, 2026 | 738,000.00 |
| Dec 31, 2025 | 793,000.00 |
| Sep 30, 2025 | 22,000.00 |
| Mar 31, 2025 | 5,000.00 |
| Dec 31, 2023 | 30,000.00 |
| Mar 31, 2022 | 27,000.00 |
| Dec 31, 2021 | 1,000.00 |
| Sep 30, 2021 | 76,000.00 |
| Mar 31, 2021 | 10,000.00 |
| Dec 31, 2020 | 58,000.00 |
| Jun 30, 2017 | 2.99 Mn |
| Mar 31, 2017 | 2.37 Mn |
| Jun 30, 2015 | 3,075.00 |
| Mar 31, 2015 | 705,542.00 |
| Jun 30, 2014 | 718,750.00 |
| Mar 31, 2014 | 5.23 Mn |
| Dec 31, 2013 | 888,562.00 |
| Sep 30, 2013 | 1.29 Mn |
| Dec 31, 2011 | 19,200.00 |